Psychiatric disorders have a very high prevalence in urban metros in India. Depression and anxiety disorders are on a rise. Selective Serotonin Reuptake Inhibitors (SSRI) are the preferred drugs for the treatment. However, their use is associated with an array of side effects some of which may even be fatal.
Genetic variations in metabolic enzymes like CYP2C19, CYP2D6, and other genes affecting the pharmacokinetics and pharmacodynamic responses to the treatment are the cause of the side effects.
SSRI drug treatment guidance test helps identify the genetic variations in patient’s DNA and helps to categorize patients into different categories based on their metabolism status of these drugs. The test detects variations in these genes that determine whether a medication could be an effective treatment or whether there is risk of side effects from a specific medication.
Who needs the test?
If you are seeing a physician for treatment of:
- Depression
- Anxiety
- Any other psychiatric disorder
SSRI drug treatment guideline test will detect your genotype and categorize you as Ultrarapid, extensive, intermediate or poor metabolizer so that your physician prescribes you the appropriate dose of drugs such as Citalopram, Escitalopramand Sertraline to ensure safety.
Sample requirement: The preferred sample is 3 mL of blood in EDTA tube or buccal swab or saliva
Turn-around-time: 5 days